These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

441 related articles for article (PubMed ID: 27269196)

  • 1. A Single-Center Pilot Prospective Study of Topical Application of Platelet-Derived Eye Drops for Patients with Ocular Chronic Graft-versus-Host Disease.
    Zallio F; Mazzucco L; Monaco F; Astori MR; Passera R; Drago G; Tamiazzo S; Rapetti M; Dolcino D; Guaschino R; Pini M; Ladetto M
    Biol Blood Marrow Transplant; 2016 Sep; 22(9):1664-1670. PubMed ID: 27269196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allogeneic serum eye drops for the treatment of dry eye patients with chronic graft-versus-host disease.
    Na KS; Kim MS
    J Ocul Pharmacol Ther; 2012 Oct; 28(5):479-83. PubMed ID: 22731244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autologous serum eye drops for the treatment of severe dry eye in patients with chronic graft-versus-host disease.
    Ogawa Y; Okamoto S; Mori T; Yamada M; Mashima Y; Watanabe R; Kuwana M; Tsubota K; Ikeda Y; Oguchi Y
    Bone Marrow Transplant; 2003 Apr; 31(7):579-83. PubMed ID: 12692625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of severe chronic ocular graft-versus-host disease using 100% autologous serum eye drops from a sealed manufacturing system: a retrospective cohort study.
    Tahmaz V; Gehlsen U; Sauerbier L; Holtick U; Engel L; Radojska S; Petrescu-Jipa VM; Scheid C; Hallek M; Gathof B; Cursiefen C; Steven P
    Br J Ophthalmol; 2017 Mar; 101(3):322-326. PubMed ID: 27267447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful treatment of dry eye in two patients with chronic graft-versus-host disease with systemic administration of FK506 and corticosteroids.
    Ogawa Y; Okamoto S; Kuwana M; Mori T; Watanabe R; Nakajima T; Yamada M; Mashima Y; Tsubota K; Oguchi Y
    Cornea; 2001 May; 20(4):430-4. PubMed ID: 11333336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allogeneic serum eye drops for the treatment of severe dry eye in patients with chronic graft-versus-host disease.
    Chiang CC; Lin JM; Chen WL; Tsai YY
    Cornea; 2007 Aug; 26(7):861-3. PubMed ID: 17667623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ocular surface and tear functions after topical cyclosporine treatment in dry eye patients with chronic graft-versus-host disease.
    Wang Y; Ogawa Y; Dogru M; Kawai M; Tatematsu Y; Uchino M; Okada N; Igarashi A; Kujira A; Fujishima H; Okamoto S; Shimazaki J; Tsubota K
    Bone Marrow Transplant; 2008 Feb; 41(3):293-302. PubMed ID: 17982500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and efficacy of autologous serum eye drop for treatment of dry eyes in graft-versus-host disease.
    Azari AA; Karadag R; Kanavi MR; Nehls S; Barney N; Kim K; Longo W; Hematti P; Juckett M
    Cutan Ocul Toxicol; 2017 Jun; 36(2):152-156. PubMed ID: 27380960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk Factors and Outcome of Chronic Graft-versus-Host Disease after Allogeneic Stem Cell Transplantation-Results from a Single-Center Observational Study.
    Grube M; Holler E; Weber D; Holler B; Herr W; Wolff D
    Biol Blood Marrow Transplant; 2016 Oct; 22(10):1781-1791. PubMed ID: 27343720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autologous serum eye drops for severe dry eye syndrome in a patient with chronic graft-versus-host disease: a case report.
    Mixon B; Mixon J; Isbey EK; Sprinkle S
    Int J Pharm Compd; 2014; 18(5):370-7. PubMed ID: 25577885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term rebamipide and diquafosol in two cases of immune-mediated dry eye.
    Yamane M; Ogawa Y; Fukui M; Kamoi M; Saijo-Ban Y; Yaguchi S; Mukai S; Kawakita T; Simmura S; Tsubota K
    Optom Vis Sci; 2015 Apr; 92(4 Suppl 1):S25-32. PubMed ID: 25785527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Corticosteroid-Free Primary Treatment of Chronic Extensive Graft-versus-Host Disease Incorporating Rituximab.
    Solomon SR; Sizemore CA; Ridgeway M; Zhang X; Smith J; Brown S; Holland HK; Morris LE; Bashey A
    Biol Blood Marrow Transplant; 2015 Sep; 21(9):1576-82. PubMed ID: 25985915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ocular Chronic Graft-versus-Host Disease and Its Relation to Other Organ Manifestations and Outcomes after Allogeneic Hematopoietic Cell Transplantation.
    Jeppesen H; Gjærde LK; Lindegaard J; Julian HO; Heegaard S; Sengeløv H
    Transplant Cell Ther; 2022 Dec; 28(12):833.e1-833.e7. PubMed ID: 36002105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ocular graft-versus-host disease.
    Hessen M; Akpek EK
    Curr Opin Allergy Clin Immunol; 2012 Oct; 12(5):540-7. PubMed ID: 22892710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topical tranilast for treatment of the early stage of mild dry eye associated with chronic GVHD.
    Ogawa Y; Dogru M; Uchino M; Tatematsu Y; Kamoi M; Yamamoto Y; Ogawa J; Ishida R; Kaido M; Hara S; Matsumoto Y; Kawakita T; Okamoto S; Tsubota K
    Bone Marrow Transplant; 2010 Mar; 45(3):565-9. PubMed ID: 19633693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosis and treatment of ocular chronic graft-versus-host disease: report from the German-Austrian-Swiss Consensus Conference on Clinical Practice in chronic GVHD.
    Dietrich-Ntoukas T; Cursiefen C; Westekemper H; Eberwein P; Reinhard T; Bertz H; Nepp J; Lawitschka A; Heiligenhaus A; Seitz B; Messmer EM; Meyer-ter-Vehn T; Basara N; Greinix H; Datiles MB; Lee SJ; Pavletic SZ; Wolff D
    Cornea; 2012 Mar; 31(3):299-310. PubMed ID: 22157574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A plethora of ocular surface manifestations in a multidisciplinary ocular graft-versus-host disease unit.
    Trindade M; Rodrigues M; Pozzebon ME; Aranha FJP; Colella MP; Fernandes A; Fornazari DO; de Almeida Borges D; Vigorito AC; Alves M
    Sci Rep; 2022 Sep; 12(1):15926. PubMed ID: 36151252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment-Sensitive and Treatment-Dependent Chronic Graft-versus-Host Disease Yield Superior Failure-Free and Overall Survival Compared to Treatment-Resistant Chronic Graft-versus-Host Disease.
    El Jurdi N; Herzog S; Shanley R; Holtan SG; MacMillan ML; Weisdorf DJ
    Transplant Cell Ther; 2024 Jun; 30(6):616-625. PubMed ID: 38479549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topical Cyclosporine Pretreatment of Ocular Surface in Allogeneic Hematopoietic Stem Cell Transplant Recipients.
    Chun YH; Beak JU; Kim HS; Na KS
    J Ocul Pharmacol Ther; 2018 Nov; 34(9):628-632. PubMed ID: 30289329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Application of Umbilical Cord Blood-derived Platelet Gel for Skin Ulcers Associated With Chronic Graft-Versus-Host Disease in Pediatrics: A Randomized Trial.
    Mohseni R; Mahdavi Sharif P; Khosravi A; Taheri AR; Behfar M; Zarrabi M; Jafari L; Jafari F; Nikfetrat Z; Naji P; Hamidieh AA
    Transplant Cell Ther; 2024 Jul; 30(7):694.e1-694.e10. PubMed ID: 38663767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.